Jun 3, 2026
Marksans Targets INR4,000cr Growth Despite Raw Inflation
Marksans Pharma Limited — Q4 FY26 Audited Financial Results (Call held May 27, 2026) 1. Overall Tone of Management: Optimistic Management highlights “highest ever profitability,” “strong...
